F. Tas Et Al. , "Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.," American journal of clinical oncology , vol.24, no.4, pp.376-8, 2001
Tas, F. Et Al. 2001. Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.. American journal of clinical oncology , vol.24, no.4 , 376-8.
Tas, F., Aydiner, A., Demir, C., & Topuz, E., (2001). Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.. American journal of clinical oncology , vol.24, no.4, 376-8.
Tas, Faruk Et Al. "Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.," American journal of clinical oncology , vol.24, no.4, 376-8, 2001
Tas, Faruk Et Al. "Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.." American journal of clinical oncology , vol.24, no.4, pp.376-8, 2001
Tas, F. Et Al. (2001) . "Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.." American journal of clinical oncology , vol.24, no.4, pp.376-8.
@article{article, author={Faruk TAŞ Et Al. }, title={Serum lactate dehydrogenase levels at presentation predict outcome of patients with limited-stage small-cell lung cancer.}, journal={American journal of clinical oncology}, year=2001, pages={376-8} }